| Model Number |
ONYXNG25030UX |
| Medical Device Problem Codes |
Material Deformation (2976); Positioning Problem (3009)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/27/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
An attempt was made to use one onyx frontier coronary drug eluting stent to treat a calcified lesion in the distal circumflex (cx) artery.It was reported that stent deformation occurred in vivo during positioning/advancement.The stent could not cross the lesion, and abnormal damage to the stent struts was visualized upon removal.A 0.014 non-medtronic guide wire was used.No patient injury reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: the lesion being treated was a calcified, moderately tortuous lesion with 80% stenosis.The device was inspected prior to use with no issues noted.The lesion was pre-dilated.Resistance was noted while advancing the device to the lesion but excessive force was not used.Lot number provided.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: annex d codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|